Consortium Reports

STI Vaccines Symposium Report

Sexually Transmitted Infection Vaccines: Opportunities for Research, Development, and Implementation was a pre-conference symposium held at the STI & HIV 2019 World Congress July 2019 in Vancouver, Canada. The goals of this unique session were to create and enhance connections with key stakeholders in the global research community; to catalyze the ground-breaking work that is currently being planned and performed; and to gain insights regarding priorities and to discuss funding.

To read the report for the STI Vaccines Symposium, please click here.

Related Websites and Blogs

Related Reports and Publications

Abraham S, Juel HB, Bang P, Cheeseman HM, Dohn RB, Cole T, et al. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminum hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet. 2019;[Online]. https://doi.org/10.1016/S1473-3099(19)30279-8.

Broutet N, Fruth U, Deal C, Gottlieb SL, Rees H. Vaccines against sexually transmitted infections: the way forward. Vaccine. 2014;32(14):1630-7. https://doi.org/10.1016/j.vaccine.2014.01.053

Cameron CE. Syphilis vaccine development: Requirements, challenges, and opportunities. Sex Transm Dis. 2018;45:S17-19. doi: 10.1097/OLQ.0000000000000831.

Chambers C, Deeks SL, Sutradhar R, Cox J, de Pokomandy A, Grennan T, et al. Anal Human Papillomavirus Prevalence Among Vaccinated and Unvaccinated Gay, Bisexual, and Other Men Who Have Sex With Men in Canada. Sex Transm Dis. 2022;49(2):123-132. doi:10.1097/OLQ.0000000000001560

Closson K, Karim ME, Sadarangani M, Naus M, Ogilvie GS, Donken R. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis. Vaccine. 2020;38(52):8396-8404. doi:10.1016/j.vaccine.2020.10.033

Donken R, Dobson SRM, Marty KD, Cook D, Sauvageau C, Gilca V, et al. Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial. Clin Infect Dis. 2020;71(4):1022-1029. doi:10.1093/cid/ciz887

Donken R, Ogilvie GS, Bettinger JA, Sadarangani M, Goldman RD. Effect of human papillomavirus vaccination on sexual behaviour among young females. Can Fam Physician. 2018;64(7): 509-513. [Online].

Grace D, Gaspar M, Paquette R, Rosenes R, Burchell AN, Grennan T, et al. HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study. PLoS One. 2018;13(11):e0207953. Published 2018 Nov 29. doi:10.1371/journal.pone.0207953

Khatra J, Sang JM, Wang C, Bacani N, Lachowsky NJ, Grennan T, et al. Longitudinal uptake of the human papillomavirus vaccine among gay, bisexual and other men who have sex with men in British Columbia, Canada 2012-2019. Sex Transm Infect. 2022;98(4):302-306. doi:10.1136/sextrans-2020-054871

Lithgow KV, Hof R, Wetherell C, Phillips D, Houston S, Cameron CE. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum. Nat Commun. 2017;8. DOI:10.1038/ncomms14273.

Lukac CD, Donken R, Otterstatter M, Mazo O, Wong S, Marra F, et al. Impacts of Human Papillomavirus Immunization Programs on Rates of Anogenital Warts in British Columbia, Canada, 2000 to 2017. Sex Transm Dis. 2020;47(10):691-697. doi:10.1097/OLQ.0000000000001235

Ogilvie GS, Naus M, Money DM, Dobson SR, Miller D, Krajden M, et al. Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis. Int J Cancer. 2015;137:1931-1937. doi:10.1002/ijc.29508

Ogilvie GS, Phan F, Pedersen HN, Dobson SR, Naus M, Saewyc EM. Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003-2013). CMAJ. 2018;190(41):E1221-E1226. doi:10.1503/cmaj.180628

Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak KL,. et al. Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ. 2007;177(12):1506-1512. https://doi.org/10.1503/cmaj.071022

Plotnikoff KM, Donken R, Smith L, Cameron C, LaMontagne DS, Bettinger JA, et al. Priorities for sexually transmitted infection vaccine research and development: Results from a survey of global leaders and representatives. Vaccine X. 2021;8:100107. doi:10.1016/j.jvacx.2021.100107

Plotnikoff KM, Ogilvie GS, Smith L, Donken R, Pedersen HN, Samji H, et al. Factors associated with interest in bacterial sexually transmitted infection vaccines at two large sexually transmitted infection clinics in British Columbia, Canada. Sex Transm Infect. 2020;96(7):494-500. doi:10.1136/sextrans-2019-054311

Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Radded LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bulletin of the World Health Organization. 2019:[Online]. http://dx.doi.org/10.2471/BLT.18.228486.

World Health Organization. Global health sector strategy on sexually transmitted infections, 2016-2021. [Online]. 2016.

World Health Organization. WHO preferred product characteristics for herpes simplex virus vaccines. [Online]. 2019.